You are here: Industry Insights > BioNTech

News List

Pfizer, BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature americanpharmaceuticalreview
February 24, 2021
Pfizer and BioNTech announced the submission of new data to the U.S. Food and Drug Administration (FDA) demonstrating the stability of their COVID-19 vaccine when stored at -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in ...
Evonik Announces Partnership with BioNTech for COVID-19 Vaccine americanpharmaceuticalreview
February 22, 2021
Evonik is investing in the short-term expansion of its specialty lipids production which are essential for mRNA-based COVID-19 vaccines.
UK to provide COVID-19 vaccine to all adults July-end expresspharma
February 22, 2021
All adults in Britain will be offered the first shot of a COVID-19 vaccine by the end of July, Prime Minister Boris Johnson said.
Pfizer, BioNTech to Supply EU with 200 Million Additional Doses of COMIRNATY americanpharmaceuticalreview
February 20, 2021
Pfizer and BioNTech announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states.
Pfizer and BioNTech begin Covid-19 vaccine trial in pregnant women pharmaceutical-technology
February 20, 2021
Pfizer and BioNTech have dosed the first participants in a global Phase II / III study of their vaccine in preventing Covid-19 in healthy pregnant women aged 18 and above.
South African variant may weaken vaccine protection: Pfizer expresspharma
February 20, 2021
The study found the vaccine was still able to neutralise the virus and there is not yet evidence from trials in people that the variant reduces vaccine protection, the companies said.
250mn Europeans to be vaccinated with COMIRNATY® by the end of 2021 europeanpharmaceuticalreview
February 19, 2021
Pfizer and BioNTech have agreed to supply the European Union with 200 million additional doses of COMIRNATY in 2021, making the total 500 million doses.
Pfizer-BioNTech’s Covid-19 vaccine-immunised sera neutralises SA variant pharmaceutical-technology
February 18, 2021
Pfizer and BioNTech have reported results from an in vitro study, which showed the capability of sera from individuals immunised with their Covid-19 vaccine (BNT162b2) in neutralising SARS-CoV-2 with the South African variant spike protein.
Research reveals Pfizer-BioNTech COVID-19 vaccine elicits strong immune response with single dose expresspharma
February 18, 2021
The response among those previously infected was so effective that it opens the debate as to whether one dose of the vaccine may suffice, the researchers said.
mRNA COVID-19 vaccine from Sanofi will not ready this year: CEO expresspharma
February 18, 2021
A COVID-19 vaccine candidate developed by Sanofi and US group Translate Bio “will not be ready this year,” said the company’s CEO to Le Journal du Dimanche newspaper.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page